Get started
Author

Alice Barinotti

Observed names: A. Barinotti, A., Barinotti, BARINOTTI, Alice, Barinotti Alice
Observed institutions: Policlinico Umberto I, Ospedale San Giovanni Bosco, Ospedale San Luigi Gonzaga, ERN ReCONNET, University of Turin, Sapienza University of Rome
ORCID: 0000-0002-7354-7002
Observed ORCID: 0000-0002-7354-7002
OpenAlex ID: A5063790465
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver
2021 · Daniele Mancardi, Mariarosa Mezzanotte, et al. · Antioxidants · 192
PDF
Renal Fibrosis in Lupus Nephritis
2022 · Savino Sciascia, Martina Cozzi, et al. · International Journal of Molecular Sciences · 61
PDF
2023 ACR/EULAR classification criteria in existing research cohorts: an international study
2024 · Silvia G Foddai, Massimo Radin, et al. · Rheumatology · 34
PDF
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review
2021 · Massimo Radin, Paolo Miraglia, et al. · American Journal of Nephrology · 34
Serum Biomarkers of Renal Fibrosis: A Systematic Review
2022 · Alice Barinotti, Massimo Radin, et al. · International Journal of Molecular Sciences · 33
PDF
Treatment of antiphospholipid syndrome
2020 · Massimo Radin, Irene Cecchi, et al. · Clinical Immunology · 32
PDF
Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
2020 · Alice Barinotti, Massimo Radin, et al. · International Journal of Molecular Sciences · 21
PDF
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence
2023 · Massimo Radin, Irene Cecchi, et al. · Seminars in Thrombosis and Hemostasis · 19
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low‐risk for chromosomal abnormalities
2020 · Silvia G. Foddai, Massimo Radin, et al. · Journal of Thrombosis and Haemostasis · 17
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
2021 · Massimo Radin, Silvia Grazietta Foddai, et al. · Orphanet Journal of Rare Diseases · 16
PDF
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
2024 · Irene Cecchi, Massimo Radin, et al. · Frontiers in Immunology · 15
PDF
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients
2022 · Massimo Radin, Elena Rubini, et al. · Clinical and Experimental Rheumatology · 15
Quality of life measures in Systemic Lupus Erythematosus: A systematic review
2022 · M. Radin, G. El Hasbani, et al. · Reumatismo · 13
PDF
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study
2022 · Massimo Radin, Karen Schreiber, et al. · Seminars in Arthritis and Rheumatism · 12
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head
2022 · Alice Barinotti, Massimo Radin, et al. · International Journal of Cardiology · 12
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol
2022 · Savino Sciascia, Massimo Radin, et al. · Clinical and Experimental Rheumatology · 12
PDF
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)
2024 · Irene Cecchi, Massimo Radin, et al. · Rheumatology · 11
PDF
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
2022 · Savino Sciascia, Alice Barinotti, et al. · Journal of Clinical Medicine · 11
PDF
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies
2022 · Massimo Radin, Alice Barinotti, et al. · Journal of Clinical Pathology · 10
Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
2020 · Massimo Radin, Irene Cecchi, et al. · Biomedicines · 10
PDF
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review
2024 · Savino Sciascia, Silvia Grazietta Foddai, et al. · Immunologic Research · 9
PDF
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
2021 · Massimo Radin, Alice Barinotti, et al. · Immunologic Research · 8
PDF
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology
2021 · Massimo Radin, Silvia Foddai, et al. · Thrombosis Research · 8
PDF
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
2023 · Savino Sciascia, Maria Letizia Antonietta Rilat, et al. · Clinical Kidney Journal · 7
PDF
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
2025 · Dario Roccatello, Alice Barinotti, et al. · Journal of Autoimmunity · 6
PDF
Works count: 78
Citation count: 693
H-index: 13
I10-index: 20
Year
Topic
Type